Perrigo | PRGO - Cost Of Sales



Perrigo reported $693.4M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
AbbVie USD 4.35B 344M Jun/2025
Abbott USD 5.27B 834M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Corcept Therapeutics USD 3.43M 1.03M Jun/2025
Dr.Reddys Laboratories INR 36.83B 8.33B Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
J&J USD 7.6B 304M Jun/2025
Merck USD 2.82B 53M Jun/2025
Nestle CHF 23.61B 1.27B Jun/2025
Pacira USD 55.19M 20.88M Jun/2025
Perrigo USD 693.4M 41.8M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Prestige Brands USD 114.38M 12.13M Jun/2025
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
Sanofi EUR 2.99B 103M Jun/2025
Supernus Pharmaceuticals USD 37.65M 21.88M Jun/2025
Teva Pharmaceutical Industries USD 2.07B 97M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025
Zoetis USD 682M 60M Jun/2025